Insmed Stock (NASDAQ:INSM), Quotes and News Summary

Q: What sector and industry does Insmed (INSM) operate in?

Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Insmed Stock (NASDAQ: INSM) stock price, news, charts, stock research, profile.

Open	$26.070
Close	$24.800
Volume / Avg.	2.300M / 1.639M
Day Range	24.770 - 26.310
52 Wk Range	17.355 - 32.000
Market Cap	$3.684B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	6.18%
Days to Cover	7.37

Recent News

Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform TikTok.

Lisa Levin

Why Lung Disease Focused Stock Insmed Is Trading Higher Today?

Insmed Incorporated (NASDAQ: INSM) shares are trading higher after the company released topline results from its Phase 3 ARISE study of ARIKAYCE in patients with newly diagnosed or recurrent nontuberculous mycobacterial (NTM) lung infection caused by Mycobacterium avium complex (MAC)

Vandana Singh

Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday

U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Insmed Inc

Sector

Health Care

Industry

Biotechnology

Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Insmed (INSM) stock?

You can purchase shares of Insmed (NASDAQ: INSM) through any online brokerage.

View our list of the best stock brokerages.

Who are Insmed's (INSM) competitors?

Other companies in Insmed’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

What is the target price for Insmed (INSM) stock?

The latest price target for Insmed (NASDAQ: INSM) was reported by Barclays on Thursday, April 11, 2024. The analyst firm set a price target for 40.00 expecting INSM to rise to within 12 months (a possible 61.29% upside). 16 analyst firms have reported ratings in the last year.

Current Stock Price for Insmed (INSM)?

The stock price for Insmed (NASDAQ: INSM) is $24.8 last updated April 18, 2024 at 4:00 PM EDT.

Does Insmed (INSM) pay a dividend?

There are no upcoming dividends for Insmed.

When is Insmed (NASDAQ:INSM) reporting earnings?

Insmed’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Insmed (INSM) going to split?

There is no upcoming split for Insmed.

What sector and industry does Insmed (INSM) operate in?

Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-